Research Paper Volume 16, Issue 2 pp 1879—1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 2. Expression of CDK16 in paired tumor and adjacent normal tissues. (A–P) CDK16 expression in paired tumor and adjacent normal tissues from TCGA in indicated tumor types. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.